ketorolac ophthalmic
Selected indexed studies
- Ketorolac 0.45% ophthalmic solution. (Drugs Aging, 2011) [PMID:21721602]
- Ketorolac. (, 2006) [PMID:30000057]
- An update on the use of ophthalmic ketorolac tromethamine 0.4%. (Expert Opin Pharmacother, 2006) [PMID:16370927]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ketorolac 0.45% ophthalmic solution. (2011) pubmed
- Systemic absorption and gastrointestinal adverse effects from topical ketorolac and diclofenac ophthalmic solutions in healthy dogs. (2024) pubmed
- Ketorolac. (2006) pubmed
- An update on the use of ophthalmic ketorolac tromethamine 0.4%. (2006) pubmed
- A Comprehensive Meta-Analysis on the Role of Analgesics and Anti-Inflammatories in Pan-Retinal Photocoagulation. (2024) pubmed
- Preformulation-Assisted Design of Ketorolac Tromethamine for Effective Ophthalmic Delivery. (2023) pubmed
- Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets. (2022) pubmed
- Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma. (2025) pubmed
- Ocular toxicology. (1997) pubmed
- Ketorolac tromethamine formulations: an overview. (2009) pubmed